Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer
US-12534530-B2 · Jan 27, 2026 · US
Perini Rodolfo Fleury is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Perini Rodolfo Fleury |
| Total patents | 12 |
| First publication | Jun 15, 2017 |
| Latest publication | Jan 27, 2026 |
Publications ranked by popularity score, then publication date.
US-12534530-B2 · Jan 27, 2026 · US
US-2025333509-A1 · Oct 30, 2025 · US
US-2024247065-A1 · Jul 25, 2024 · US
US-2024010729-A1 · Jan 11, 2024 · US
US-2023250182-A1 · Aug 10, 2023 · US
US-2023210838-A1 · Jul 6, 2023 · US
US-2023118596-A1 · Apr 20, 2023 · US
US-2023058779-A1 · Feb 23, 2023 · US
US-2022324979-A1 · Oct 13, 2022 · US
US-2020325228-A1 · Oct 15, 2020 · US
Latest publications not already listed above.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme Llc | 8 |
| Pfizer | 5 |
| Merck Sharp & Dohme | 4 |
| Eisai R&D Man Co Ltd | 4 |
| Merck Sharpe & Dohme Corp | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 12 |
| A61K45/06 | 11 |
| C07K16/2818 | 11 |
| A61K2039/545 | 11 |
| A61K2039/505 | 11 |